Accessibility Tools

A Retrospective Community Based Study Evaluating Disability in Migraine Patients Treated with Erenumab-aoee. American Headache Society 61st Annual Scientific Meeting. Philadelphia, PA July 11-14, 2019

A Two-Year Retrospective Review: Community-Based Outpatient Infusion Center Acute Treatment of Refractory Migraine. American Headache Society 58th Annual Scientific Meeting, San Diego, CA, June 10, 2016.

Chart Review of Lymphocyte Reconstitution Among MS Patients After Discontinuation of Dimethyl Fumarate American Academy of Neurology, 2021 Virtual Annual Meeting, April 17-22, 2021

Comparison of Skin Cell Immunity in Patients Receiving Treatment with Gilenya (fingolimod) and Healthy Controls. 7th Joint ECTRIMS - ACTRIMS Meeting Paris, France, October 25-28, 2017

Is Chronic Migraine More Common in the Multiple Sclerosis Population? American Headache Society 59th Annual Scientific Meeting. Boston, MA June 9, 2017

Sustained efficacy of botulinum toxin type-A (BTXA) on migraine-related disability over 3 treatment cycles in a community-based setting. Cephalalgia, 29 (Suppl 1) (2009) 145.

Our Research Team

True North Clinical Research is dedicated to expanding the field of Neurology through cutting edge research and clinical trials focused on improving patient outcomes


6080 Jericho Turnpike
Suite 100
Commack, NY 11725

Port Jefferson

1010 NY Route 112
Suite 300
Port Jefferson Station, NY 11776